Posted by Michael Wonder on 22 Nov 2022
NICE recommends Sobi’s Doptelet to treat thrombocytopenia
18 November 2022 - Primary ITP is a rare autoimmune condition characterised by high platelet destruction
Sobi has announced that NICE has issued the Final Appraisal Document in England and Wales recommending the use of Doptelet.
